GCM
PBH icon

Gladius Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Gladius Capital Management’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-513
Closed -$35.3K – 339
2024
Q2 		$35.3K Buy
+513
New +$34.8K ﹤0.01% 190
2023
Q2 		– Sell
-552
Closed -$34.6K – 438
2023
Q1 		$34.6K Sell
552
-66
-11% -$4.12K ﹤0.01% 261
2022
Q4 		$38.7K Sell
618
-79
-11% -$4.53K ﹤0.01% 232
2022
Q3 		$35K Sell
697
-668
-49% -$37K ﹤0.01% 260
2022
Q2 		$81K Buy
+1,365
New +$75.3K ﹤0.01% 212

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Gladius Capital Management's PBH Position: Q3 2024 in Review

Gladius Capital Management sold out of Prestige Consumer Healthcare (PBH) in Q3 2024, closing a stake of 513 shares — an estimated $35.3K sold.

Gladius Capital Management first reported a position in PBH in Q2 2022 and held it in 5 quarters. The position peaked at $81K in Q2 2022. 328 funds tracked by Wall St. Rank hold PBH as of Q3 2024.

  • Gladius Capital Management reported no remaining Prestige Consumer Healthcare position as of Q3 2024 after selling out during the quarter.
  • Gladius Capital Management sold 513 Prestige Consumer Healthcare shares in Q3 2024, an estimated $35.3K.
  • Gladius Capital Management first reported a position in Prestige Consumer Healthcare in Q2 2022 and held it in 5 quarters.
  • Gladius Capital Management's Prestige Consumer Healthcare position peaked at $81K in Q2 2022.
  • 328 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2024.

Based on Gladius Capital Management's 13F filing for Q3 2024, filed 6 Nov 2024.